Home

Home

20 years of MIS

By Professor Ferdinand Köckerling MD, President of the DGVC, Head of the Clinic for Surgery, Visceral and Vascular Surgery, at the Centre for Minimal Invasive Surgery, Vivantes Hospital Spandau, Berlin

Scientific studies confirm that after 20 years of minimally invasive surgery (MIS) most of these operations have advantages over the equivalent, conventional surgical procedures.

article image

Professor Ferdinand Köckerling MD

For example, minimally invasive removal of the gall bladder, the method chosen in Germany for about 85% of cases, results in less pain and a shorter hospital stay by comparison, even if the conventional removal is performed with only a very small incision. Endoscopic appendix removal compared to the conventional surgical procedure also involves less pain, shorter hospital stay and earlier return to full activity. Due to the lower rate of complications even in complicated cases, this also means lower treatment costs for endoscopic appendix removal. Despite this, minimally invasive appendix removal is currently only performed in around 50% of cases, because an experienced surgical team is not always available, particularly at night and during weekends.
Meta-analysis shows that endoscopic hernia operations carry lower risks of wound infection, fewer haematomas and injuries to nerves and earlier return to normal activity for the patient. The same rates of success also apply to bilateral hernia operations, which occur in up to 30% of cases. Despite these advantages only around 35% of hernia operations are carried out in Germany with MIS — again due to the lack of highly trained surgeons in MIS.
The majority of laparoscopic fundoplication procedures for reflux are now carried out minimally invasively. 10 years after minimally invasive fundoplication, the quality of life for patients is significantly better than that achieved with medicinal therapy. The use of MIS for tumour removal must still be viewed with criticism, although it has now been proven that, for patients with cancer of the large intestine, endoscopic surgery can achieve comparatively good long term results if the right patients are chosen for the procedure.
The key problem for the further MIS development is the long learning curve, i.e. surgeons need to have performed a certain endoscopic operation very frequently until they have mastered it in all situations. To meet this requirement the Surgical Working Group for Minimally Invasive Surgery (CAMIC) of the German Society  for Visceral Surgery (DGVC) has instigated certification procedures for surgeons and reference centres. These certificates are only awarded if a surgeon or a hospital meets certain conditions (case numbers, equipment, training) and passes an audit by experts. As the responsible scientific associations, the DGVC and the CAMIC hope for quality assurance and quality improvements in training and therapy for the benefit of patients.

This article was published on 07/01/2008

Search

 

Service

Company News

Accu-Chek® Combo – put effective diabetes management into action

At the annual congress of the European Association for the Study of Diabetes (EASD) this year in Rome, Roche Diabetes Care introduced Accu-Chek Combo – the insulin pump system that combines an insulin pump with an intelligent glucose monitoring system, a bolus calculator, and an integrated pump remote-control.

Products redesigned to help patients simplify life with diabetes

Bayer HealthCare Diabetes Care unveiled the new
CONTOUR® blood glucose meter with enhanced testing features at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome, Italy.

Carestream: technical infrastructure for EU funded R-bay project

Carestream Health is a major technical infrastructure provider to the EU-funded R-Bay validation project, which aims to address the uneven spread of radiologists across member states. CARESTREAM Radiology and Information Management Solutions are driving the initial test platform for the project by facilitating remote reporting of images from hospitals in Denmark, Finland and Czech Republic by clinical providers in Estonia, Lithuania and the Netherlands.